Health Equity

Cecilia BrownUrothelial Carcinoma | September 1, 2022
Dr. Mary Beth Westerman, speaks on notable advances that she has see in bladder cancer throughout her career.
Read More
Cecilia BrownUrothelial Carcinoma | September 1, 2022
Dr. Westerman speaks on what clinicians can do to improve pre-operative counseling for female patients with bladder cancer.
Cecilia BrownUrothelial Carcinoma | September 1, 2022
Dr. Mary Beth Westerman provides insight on some of the main challenges in treating women with bladder cancer.
Akhil Abraham Saji, MDJournal | August 24, 2022
A review of a series of articles published by Urology on diversity, equity, and inclusion findings in prostate cancer care.
Leah LawrenceProstate Cancer | August 18, 2022
Delays in the initiation of intensity-modulated radiotherapy may contribute to known differences in cancer outcomes.
Leah LawrenceProstate Cancer | August 8, 2022
Annual screening compared with “some screening” was associated with a significant reduction of PCSM risk for Black men.
GU Oncology Now EditorsmCRPC | June 2, 2022
Researchers evaluate the frequency of germline DDRg mutations in metastatic prostate cancer patients of different ancestries.
GU Oncology Now EditorsRenal Cell Carcinoma | June 1, 2022
The South Texas region, with a predominantly Latinx population, has a very high incidence of renal cell carcinoma.
GU Oncology Now EditorsProstate Cancer | June 1, 2022
This study offers a realist approach to rethinking and operationalizing the WHO 2017 guide to cancer early diagnosis.
GU Oncology Now EditorsProstate Cancer | May 26, 2022
The study examines a cohort of prostate cancer patients who underwent external beam radiation therapy from 1990 to 2017.
GU Oncology Now EditorsRenal Cell Carcinoma | May 26, 2022
At present, there are few studies on renal pelvic transitional cell carcinoma (RPTCC) in elderly patients in the literature.
GU Oncology Now EditorsProstate Cancer | May 23, 2022
Sexual and gender minority persons face disproportionate risks for and rates of many cancers, including prostate cancer.
GU Oncology Now EditorsProstate Cancer | May 22, 2022
Prior to this, no national curative treatment for recurrent prostate cancer following radiation therapy existed in Denmark.
GU Oncology Now EditorsLocalized Prostate Cancer | May 20, 2022
The propensity score matching investigated the medical expenditure of RP and IMRT in elderly patients with high-risk LPC.
Vanessa IraAUA 2022 | May 17, 2022
Minorities experience disparities in shared decision-making when it comes to discussions on the advantages of PSA testing.
Researchers co-created the video with African and African-Caribbean men and promoted it throughout Black History Month.
HealthDay NewsProstate Cancer | January 5, 2022
Analysis shows that radiation therapy seems to work better for Black men with prostate cancer than for their White peers.
GU Oncology Now EditorsSUO Annual Meeting 2021 | December 3, 2021
Researchers evaluate PSA screening frequency and the effect of different screening intensities on prostate cancer diagnoses.
GU Oncology Now EditorsSUO Annual Meeting 2021 | December 2, 2021
Researchers observed treatment for MIBC in academic facilities didn’t mitigate poorer outcomes for disadvantaged ...
GU Oncology Now EditorsSUO Annual Meeting 2021 | December 1, 2021
For prostate cancer patients, variables like definitive treatment and time to treatment initiation are inferior at HSDPs.
Advertisement
Advertisement